TitleAbsorptive constituents and their metabolites in drug-containing urine samples from Wuzhishan miniature pigs orally administered with Buyang Huanwu decoction
AuthorsYang, Dong-Hui
Ren, Xiang-Liang
Xu, Feng
Ma, Xiao-Qing
Liu, Guang-Xue
Li, Cang-Hai
Li, Chen
Cai, Shao-Qing
AffiliationPeking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
KeywordsBuyang Huanwu decoction
Isoflavonoid
Drug-containing urine
WZS miniature pig
ASTRAGALUS-MEMBRANACEUS
SOY ISOFLAVONES
IDENTIFICATION
PTEROCARPAN
EQUOL
PHARMACOLOGY
MONGHOLICUS
CHEMISTRY
GENISTEIN
DAIDZEIN
Issue Date2014
Publisherjournal of natural medicines
CitationJOURNAL OF NATURAL MEDICINES.2014,68,(1),11-21.
AbstractBuyang Huanwu decoction (BYHWD), a famous traditional Chinese medicine prescription for the treatment of cerebrovascular diseases, is composed of seven commonly used Chinese herbs-Astragali Radix, Angelicae Sinensis Radix, Paeoniae Radix Rubra, Chuanxiong Rhizoma, Carthami Flos, Persicae Semen and Pheretima. To determine the main absorptive constituents and the metabolites of BYHWD in vivo, urine samples from Wuzhishan (WZS) miniature pigs orally administered with BYHWD (13.6 g crude drugs/kg) were collected to investigate the characteristic compounds. By comparing the high-performance liquid chromatography of a drug-containing urine sample with that of a drug-free sample, 17 characteristic compounds were isolated from the methanol extract of a drug-containing urine sample by column chromatography. Their structures, including 11 isoflavanoids, 2 pterocarpanoids and 4 isoflavonoids, were identified by spectroscopic means. Of the 17 compounds, 8 (1-8) were new compounds with the following structures: 3S-7,3',4'-trihydroxyisoflavan-3'-O-beta-d-glucuronide (1), 3S-7,3',4'-trihydroxyisoflavan-4'-O-beta-d-glucuronide (2), 3S-7,2',4'-trihydroxyisoflavan-2'-O-beta-d-glucuronide (3), 3R-7,2'-dihydroxy-3',4'-dimethoxyisoflavan-2'-O-beta-d-glucuronide (4), 3R-7,2'-dihydroxy-3',4'-dimethoxyisoflavan-2'-O-beta-d-glucuronide-6aEuro(3)-methyl ester (5), 3R-7,2'-dihydroxy-3',4'-dimethoxyisoflavan-7-O-beta-d-glucuronide-6aEuro(3)-methyl ester (6), 3R-7,2',3'-trihydroxy-4'-methoxyisoflavan-3'-O-beta-d-glucuronide-6aEuro(3)-methyl ester (7), and 3S-7,4',5'-trihydroxy-2',3'-dimethoxyisoflavan-5'-O-beta-d-glucuronide (8). Based on the possible relationship and metabolic pathways of the 17 compounds in vivo, 3R-7,2'-dihydroxy-3',4'-dimethoxyisoflavan (isomucronulatol, 11), 6aR,11aR-3-hydroxy-9,10-dimethoxypterocarpan (methylnissolin, astrapterocarpan, 13), 7,3'-dihydroxy-4'-methoxyisoflavone (calycosin, 16) and 7-hydroxy-4'-methoxyisoflavone (formononetin, 17) were thought to be the most important absorptive original isoflavonoid constituents of BYHWD in vivo, which underwent reactions of glucuronidation, hydroxylation, demethylation and reduction. The other 13 compounds were deduced to be their metabolites.
URIhttp://hdl.handle.net/20.500.11897/156462
ISSN1340-3443
DOI10.1007/s11418-013-0756-1
IndexedSCI(E)
PubMed
Appears in Collections:药学院
天然药物与仿生药物国家重点实验室

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.